Silencing Lyn kinase overcomes resistance to imatinib in Bcr-Abl-dependent CML cells

被引：0
|
作者：
Wu, Ji Yuan [1 ]
Talpaz, Moshe [1 ]
Donato, Nicholas J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2345
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The importance of Bcr-Abl-dependent EpCAM Expression for the Treatment of Treatment Resistance of CML
    Towhidi, T.
    Zhuang, R.
    Jucker, M.
    Boddu, V. K.
    Gires, O.
    Busch, H.
    Illert, L.
    Duyster, J.
    Gemoll, T.
    Gieseler, F.
    Von Bubnoff, N.
    Gorantla, S. Prasad
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 121 - 121
  • [2] Investigation of the mechanism of USP28-mediated IFITM3 elevation in BCR-ABL-dependent imatinib resistance in CML
    Li, Zilin
    Xi, Yiling
    Zhang, Xu
    Huang, Yue
    Nie, Huizong
    Peng, Cheng
    Chai, Haohuan
    Zeng, Shenxin
    Zheng, Xiaoliang
    Cheng, Liyan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [3] Not all imatinib resistance in CML are BCR-ABL kinase domain mutations
    Wei, Yuan
    Hardling, Mats
    Olsson, Bob
    Hezaveh, Rahil
    Ricksten, Anne
    Stockelberg, Dick
    Wadenvik, Hans
    ANNALS OF HEMATOLOGY, 2006, 85 (12) : 841 - 847
  • [4] Not all imatinib resistance in CML are BCR-ABL kinase domain mutations
    Yuan Wei
    Mats Hardling
    Bob Olsson
    Rahil Hezaveh
    Anne Ricksten
    Dick Stockelberg
    Hans Wadenvik
    Annals of Hematology, 2006, 85 : 841 - 847
  • [5] An alternative Abl-kinase inhibitor overcomes imatinib resistance in cells expressing mutant forms of Bcr-Abl
    von Bubnoff, N
    Peschel, C
    Duyster, J
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (40) : 2100 - 2103
  • [6] Sequential blockade of Bcr-Abl production overcomes resistance to imatinib
    Chen, Rong
    Plunkett, William
    CANCER RESEARCH, 2006, 66 (08)
  • [7] Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosis
    Snead, Jennifer L.
    O'Hare, Thomas
    Adrian, Lauren T.
    Eide, Christopher A.
    Lange, Thoralf
    Druker, Brian J.
    Deininger, Michael W.
    BLOOD, 2009, 114 (16) : 3459 - 3463
  • [8] Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells
    Carter, BZ
    Mak, DH
    Schober, WD
    Cabreira-Hansen, M
    Beran, M
    McQueen, T
    Chen, WJ
    Andreeff, M
    BLOOD, 2006, 107 (04) : 1555 - 1563
  • [9] ICSBP DEFICIENCY IN CML CONFERS DIRECT BCR/ABL-INDEPENDENT IMATINIB RESISTANCE BUT RESTRICTS BCR/ABL KINASE POINT MUTATION DEVELOPMENT
    Chaturvedi, A.
    Schmidt, K.
    Neubauer, A.
    Burchert, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 422 - 422
  • [10] Signaling Networks Associated With BCR-ABL-Dependent Transformation
    Hazlehurst, Lori A.
    Bewry, Nadine N.
    Nair, Rajesh R.
    Pinilla-Ibarz, Javier
    CANCER CONTROL, 2009, 16 (02) : 100 - 107
12345